The Charles Stark Draper Laboratory Inc. has inked a three year partnership with Pfizer to create personalised versions of Draper’s Microphysiological Systems (MPS), for cheaper and more effective preclinical testing.
The EMA has started reviewing drugs tested by Micro Therapeutic Research Labs after an inspection by Dutch and Austrian regulators identified potential data integrity problems.
Catalent has partnered with US non-profit PATH for antibody discovery using the CDMO’s GPEx cell line platform, funded by PATH’s Malaria Vaccine Initiative (MVI).
Turnover in the US for clinical monitoring jobs at contract research organizations (CROs) has remained high despite efforts to increase salaries, according to a recent report.
Baxter International has agreed to pay Claris Lifesciences $625m (€598m) for three manufacturing facilities and a portfolio of 11 approved injectable drugs.
NanoTemper Technologies Gmbh has scored custom from the UK CRO Domainex Ltd., which is using its MicroScale Thermophoresis technology for speedier, “higher quality clinical candidates”.
Bangalore’s Strides Shasun Ltd. has acquired Perrigo API India ltd and its active pharmaceutical manufacturing portfolio for generics for INR1bn ($14.7m).
As holidays shoppers wrap up their presents with ribbons and bows, Outsourcing-Pharma.com reviews how contract pharmaceutical packaging companies help ensure successful patient outcomes with iterative design.
Almac Clinical Technologies, part of the Almac Group, has announced a collaboration with Exostar to help mitigate risk associated with intellectual property.
Total spending on medicines is expected to reach $1.5 trillion by 2021, up 33% from 2016 – with historical amounts of new medicines emerging from the pipeline, according to a recent report by QuintilesIMS Institute.
Smithers Avanza is granted renewal of full accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC), with “no recommendation for improvements.”
bluebird bio Inc has hired apceth Biopharma GmbH to make its candidate ALD cell therapy Lenti-D and its thalassemia treatment LentiGlobin for the European market.
Lonza has agreed to buy US capsule manufacturer Capsugel for $5.5bn (€5.2bn) in cash in an acquisition the Swiss firm says will expand its drug delivery business and enable savings of CHF100m a year by 2019.
Earlier this week, INC Research announced its intent to expand at its headquarters in Wake County, creating 550 jobs over the next several years as part of a $37.9m investment.
The US FDA has criticized Pocono Coated Products' (PCP) efforts to bring its transdermal patch plant in Cherryville, North Carolina into compliance with cGMP standards.
Newly identified impurities in sugar excipients pose a risk to patients and could explain why some drugs fail safety tests according to scientists from the Netherlands.
Through the collaboration, Purdue will leverage Exicure’s Spherical Nucleic Acid (SNA)™ technology to discover and develop a treatment for psoriasis, and other diseases.
The Slovakian Government has granted Saneca Pharma €1.5m ($1.6m) to invest in ‘green’ API manufacturing and anti-abuse technologies for its opiate-based drugs.
Avid Bioservices has reported strong contract manufacturing revenues for its Q2 and is confident a planned third facility will not leave the firm with too much capacity.
The Institute claims SNBL USA has committed dozens of violations to the Animal Welfare Act and demands more severe consequences from the US Department of Agriculture.
Aptar Pharma is nearing completion of its US-based manufacturing site, as it continues to expand globally to keep pace with growth in the injectable drug delivery industry.
The “Bring Your Own Device” (BYOD) continues to gain momentum with ERT’s acquisition of Exco InTouch, a provider of patient engagement, data capture, and digital health solutions.
Catalent has become the first CDMO to join the PSCI – a voluntary industry initiative focused on the social, environmental and economic impact of the supply chain.
Swedish Orphan Biovitrum AB (Sobi) and Horizon Pharma plc have teamed up for a 5-year deal to distribute urea cycle disorder drugs Ravicti and Ammonaps in Europe and the Middle East.
Fareva Group has set up an aerosol manufacturing facility at its site in Richmond, Virginia as part of a $40m (€37m) investment in its drug, OTC medicine and beauty care business.
